Publications - IR Sant Pau

Search

01/04/2025 Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock-CAT study

García-García, C, López-Sobrino, T, Sanz-Girgas, E, Cueto, MR, Aboal, J, Pastor, P, Buera, I, Sionis, A, Andrea, R, Rodríguez-López, J, Sánchez-Salado, JC, Tomas, C, Bañeras, J, Ariza, A, Lupón, J, Bayés-Genís, A, Rueda, F. Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock-CAT study. ESC Heart Failure. 2025; 12(2)DOI:10.1002/ehf2.15148. PMID:39587711. IF:3.700(Q1/3D).

01/04/2025 Early and late hospital readmissions after percutaneous left atrial appendage closure

Trinh, KH, Nuche, J, Cruz-González, I, Guedeney, P, Arzamendi, D, Freixa, X, Nombela-Franco, L, Peral, V, Caneiro-Queija, B, Mangieri, A, Trejo-Velasco, B, Asmarats, L, Cepas-Guillén, P, Salinas, P, Siquier-Padilla, J, Estevez-Loureiro, R, Laricchia, A, O'hara, G, Montalescot, G, Côté, M, Mesnier, J, Rodés-Cabau, J. Early and late hospital readmissions after percutaneous left atrial appendage closure. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(4)DOI:10.1016/j.rec.2024.07.009. PMID:39128822. IF:4.900(Q1/2D).

01/04/2025 Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop

Pearce, L, Galán-Arriola, C, Bell, RM, Carr, RD, Cunningham, J, Davidson, SM, Ghosh, AK, Giesz, S, Golforoush, P, Gourine, AV, Hermann, DM, Heusch, G, Ibanez, B, Kalkhoran, SB, Lecour, S, Lukhna, K, Ntsekhe, M, Sack, MN, Unwin, RJ, Vilahur, G, Walker, JM, Yellon, DM. Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop. BASIC RESEARCH IN CARDIOLOGY. 2025; 120(2)DOI:10.1007/s00395-024-01094-6. PMID:39681732. IF:8.000(Q1/1D).

01/04/2025 From mice to humans: advancing the path to cardioprotection

Badimon, L, Vilahur, G, Mendieta, G. From mice to humans: advancing the path to cardioprotection. CARDIOVASCULAR RESEARCH. 2025; 121(5)DOI:10.1093/cvr/cvaf048. PMID:40113589. IF:13.300(Q1/1D).

01/04/2025 Transitioning between automated insulin delivery systems: A focus on personalisation

Beato-Víbora, PI, Chico, A, Moreno-Fernandez, J, Azriel-Mira, S, Nattero-Chávez, L, Mora, RV, Alonso-Carril, N, Simó-Servat, O, Aguilera-Hurtado, E, Céspedes, LMR, de Adana, MR, Domínguez, M, Márquez-Pardo, R, Díaz-Soto, G, Martínez-Brocca, MA, Fernández, KA, Buesa, MA, Hernández, MC, Quirós, C. Transitioning between automated insulin delivery systems: A focus on personalisation. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 222DOI:10.1016/j.diabres.2025.112070. PMID:40020785. IF:7.400(Q1/1D).

01/04/2025 Clinical characteristics and management of type 2 diabetes in primary care in Spain. SED2 Study

Antonio-Arques, V, Camins, BF, Vlacho, B, Barrot, J, Pérez, JN, Torre, EM, Mauricio, D, Franch-Nadal, J. Clinical characteristics and management of type 2 diabetes in primary care in Spain. SED2 Study. Endocrinologia Diabetes y Nutricion. 2025; 72(4)DOI:10.1016/j.endien.2025.501543. PMID:40180835. IF:1.800(Q3/8D).

01/04/2025 Age-related differences in the clinical features and management of pituitary apoplexy: a cohort study

Asanza, EC, Biroli, A, Pérez-López, C, Araujo-Castro, M, Cámara, R, Guerrero-Pérez, F, Vicente, A, Lamas, C, Serra, G, Echarri, AI, Ollero, MD, Molero, I, Villar-Taibo, R, Rodríguez, MDM, Feijoo, PG, Berrocal, VR, Sánchez, N, Hurtado, AG, Capristan-Díaz, V, Simó-Servat, A, Gallach, M, Pérez, ES, Rosa, VG, Modino, SC, Torre, EM, Aulinas, A, Iglesias, P, Diez, JJ, Rodriguez-Hernández, V, Puig-Pérez, A, Blangini, E, Bernabéu, I, Alvarez-Escolá, C, Sarria-Estrada, S, Puig-Domingo, M, Abelló, FA, Martínez-Sáez, E, Biagetti, B. Age-related differences in the clinical features and management of pituitary apoplexy: a cohort study. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2025; 192(4)DOI:10.1093/ejendo/lvaf056. PMID:40129106. IF:5.200(Q1/2D).

01/04/2025 Preventing the progression of cirrhosis to decompensation and death

Villanueva, C, Tripathi, D, Bosch, J. Preventing the progression of cirrhosis to decompensation and death. Nature Reviews Gastroenterology & Hepatology. 2025; 22(4)DOI:10.1038/s41575-024-01031-x. PMID:39870944. IF:51.000(Q1/1D).

01/04/2025 Recompensation in Cirrhosis: Biomarkers and Strategies

Ramírez-Quesada, W, Alvarado-Tapias, E, Shalaby, S, Hernández-Gea, V. Recompensation in Cirrhosis: Biomarkers and Strategies. SEMINARS IN LIVER DISEASE. 2025; 45(01)DOI:10.1055/a-2542-9930. PMID:40179966. IF:3.700(Q2/3D).

01/04/2025 Moderate alcohol-associated hepatitis: A real-world multicenter study

Idalsoaga, F, Díaz, LA, Dunn, W, Mehta, H, Muñoz, K, Caldentey, V, Arnold, J, Ayares, G, Mortuza, R, Sarin, SK, Maiwall, R, Zhang, W, Qian, S, Simonetto, D, Singal, AK, Elfeki, MA, Ramirez-Cadiz, C, Malhi, G, Ahmed, A, Homsi, H, Abid, Z, Cabezas, J, Echavarría, V, Poca, M, Soriano, G, Cuyas, B, Cots, MV, Higuera-De La Tijera, MF, Ayala-Valverde, M, Perez, D, Gomez, J, Abraldes, JG, Al-Karaghouli, M, Jalal, PK, Ibrahim, MA, García-Tsao, G, Goyes, D, Skladany, L, Havaj, DJ, Sulejova, K, Selcanova, SA, Rincón, D, Chacko, KR, Restrepo, JC, Yaquich, P, Toro, LG, Shah, V, Arrese, M, Kamath, PS, Bataller, R, Arab, JP. Moderate alcohol-associated hepatitis: A real-world multicenter study. Hepatology Communications. 2025; 9(4)DOI:10.1097/HC9.0000000000000673. PMID:40131003. IF:4.600(Q1/2D).

01/04/2025 Whole Genome Sequencing Analysis of Klebsiella pneumoniae Isolates from Health Care-Associated Bacteremia of Urinary Origin in Spain: Findings from the Multicenter ITUBRAS-2 Cohort Study

Becerra-Aparicio, F, Gómez-Zorrilla, S, Hernández-García, M, Xanthopoulou, K, Gijón, D, Siverio, A, Berbel, D, Cercenado, E, Rivera, A, De Malet, A, Xercavins, M, De Gopegui, ER, Canoura-Fernández, L, Martínez, JA, Seral, C, Del Pozo, JL, Cotarelo, M, Ponz, R, Higgins, PG, Durán-Jordà, X, Cantón, R, Oliver, A, Horcajada, JP, Ruiz-Garbajosa, P. Whole Genome Sequencing Analysis of Klebsiella pneumoniae Isolates from Health Care-Associated Bacteremia of Urinary Origin in Spain: Findings from the Multicenter ITUBRAS-2 Cohort Study. Open Forum Infectious Diseases. 2025; 12(4)DOI:10.1093/ofid/ofaf164. PMID:40201725. IF:3.800(Q1/3D).

01/04/2025 Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry

Oscullo, G, Méndez, R, Olveira, C, Girón, R, García-Clemente, M, Máiz, L, Sibila, O, Golpe, R, Rodríguez-Hermosa, J, Barreiro, E, Prados, C, Rodríguez-López, JL, de la Rosa-carrillo, D, Martinez-García, MA. Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(4)DOI:10.1016/j.arbres.2025.02.015. PMID:40180519. IF:9.200(Q1/1D).

01/04/2025 Unraveling the Molecular Mechanisms of OSA-Related Cardiovascular Event Recurrence: A Post Hoc Analysis From the ISAACC Study

Zapater, A, Pinilla, L, Gracia-Lavedan, E, Targa, A, Torres, G, Mínguez, O, Pascual, L, Cortijo, A, Martínez, D, Benítez, ID, García-Hidalgo, MC, De Batlle, J, Abad, J, Duran-Cantolla, J, Urrutia, A, Mediano, O, Masdeu, MJ, Ordax-Carbajo, E, Masa, JF, De la Peña, M, Mayos, M, Coloma, R, Montserrat, JM, Chiner, E, Roncero, A, Sanz-Rubio, D, Barbé, F, Sánchez-de-la-Torre, M. Unraveling the Molecular Mechanisms of OSA-Related Cardiovascular Event Recurrence: A Post Hoc Analysis From the ISAACC Study. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(4)DOI:10.1016/j.arbres.2024.09.008. PMID:39438203. IF:9.200(Q1/1D).

01/04/2025 Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial

Bermudo-Peloche, G, Del Rio, B, Vicens-Zygmunt, V, Bordas-Martinez, J, Hernández, M, Valenzuela, C, Laporta, R, Bobillo, JR, Portillo, K, Millán-Billi, P, Balcells, E, Badenes-Bonet, D, Bolivar, S, Rodríguez-Portal, JA, Ramirez, CL, Tomás, L, Roitegi, KFD, Sellarés, J, Castillo, D, González, J, Barril, S, Gutiérrez-Rodríguez, Y, Caballero, P, Alarcon, J, Peñafiel, J, Sanz-Santos, J, Blavia, R, Caupena, C, Segovia, P, Santos-Pérez, S, Ferrer-Artola, A, Badia, MB, Hereu, P, Fuentes, M, Montes-Worboys, A, Franquet, T, Luburich, P, Molina-Molina, M. Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial. EUROPEAN RESPIRATORY JOURNAL. 2025; 65(4)DOI:10.1183/13993003.02249-2024. PMID:40154560. IF:21.000(Q1/1D).

01/04/2025 Antiviral effect, safety, and tolerability of the third-generation integrase strand transfer inhibitor VH4524184 (VH-184): a proof-of-concept trial

Rogg, L, Nuñez, SA, Mingrone, MVO, Domingo, P, Lopez, M, Hanan, N, Ghita, GL, Jeffrey, JL, Underwood, M, Castillo-Mancilla, JR, Halliday, F, Ezeadi, E, Gartland, M. Antiviral effect, safety, and tolerability of the third-generation integrase strand transfer inhibitor VH4524184 (VH-184): a proof-of-concept trial. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

01/04/2025 Will I feel better? Raising the bar for quality of life in oncology

Tibau, A, Romano, A, Kesselheim, AS. Will I feel better? Raising the bar for quality of life in oncology. Nature Reviews Clinical Oncology. 2025; 22(4)DOI:10.1038/s41571-025-01002-4. PMID:40021787. IF:82.200(Q1/1D).

01/04/2025 Retifanlimab in Advanced Penile Squamous Cell Carcinoma: The Phase 2 ORPHEUS Study

Del Muro, XG, López-Bravo, DP, Cuéllar-Rivas, MA, Maroto, P, Giannatempo, P, Castellano, D, Climent, MA, Valderrama, BP, de Liaño, AG, López-Montero, L, Mina, L, Alcalá-López, D, Sampayo-Cordero, M, Necchi, A. Retifanlimab in Advanced Penile Squamous Cell Carcinoma: The Phase 2 ORPHEUS Study. European Urology Oncology. 2025; 8(2)DOI:10.1016/j.euo.2024.04.021. PMID:38749903. IF:9.300(Q1/1D).

01/04/2025 A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial

Soo, RA, Vervita, K, Früh, M, Cho, B, Majem, M, Abreu, DR, Ribi, K, Callejo, A, Moran, T, Gomez, MD, Provencio, M, Addeo, A, Han, JY, Granados, ALO, Reck, M, Blasco, A, Campelo, RG, González, MAS, Britschgi, C, Roschitzki-Voser, H, Ruepp, B, Gasca-Ruchti, A, Haberecker, M, Dafni, U, Peters, S, Stahel, RA. A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial. LUNG CANCER. 2025; 202DOI:10.1016/j.lungcan.2025.108454. PMID:40023017. IF:4.400(Q1/2D).

01/04/2025 Woake's Syndrome Abscessed in Adults: Case Report

Holgado, A, Casasayas, M, Llansana, A, Gras, JR. Woake's Syndrome Abscessed in Adults: Case Report. Indian Journal of Otolaryngology and Head & Neck Surgery. 2025; 77(4)DOI:10.1007/s12070-024-05285-4. PMID:40226287. IF:0.054(Q4/10D).

01/04/2025 The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide

Spyridonidis, A, Labopin, M, Savani, BP, Kulagin, A, Blaise, D, Broers, AEC, Sica, S, Raiola, AM, Vydra, J, Choi, G, Rovira, M, Kwon, M, Sanz, J, Itäla-Remes, M, von dem Borne, P, Esquirol, A, Koc, Y, Brissot, E, Nagler, A, Mohty, M, Ciceri, F. The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide. BONE MARROW TRANSPLANTATION. 2025; 60(4)DOI:10.1038/s41409-025-02514-4. PMID:39910175. IF:5.200(Q1/1D).

01/04/2025 Nerve growth factor precursor alterations in neuron-derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum

Valle-Tamayo, N, Aranha, MR, Pérez-González, R, Serrano-Requena, S, Videla, L, Barroeta, I, Benejam, B, Chiva-Blanch, G, Jimenez, A, Busciglio, J, Wisniewski, T, Do Carmo, S, Alvarez-Sánchez, E, Muñoz, L, Bejanin, A, Belbin, O, Alcolea, D, Carmona-Iragui, M, Lleó, A, Cuello, AC, Fortea, J, Dols-Icardo, O, Iulita, MF. Nerve growth factor precursor alterations in neuron-derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.70137. PMID:40257051. IF:11.100(Q1/1D).

01/04/2025 Plasma p-tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease

Kac, PR, Alcolea, D, Montoliu-Gaya, L, Fernández, S, Rodriguez, JL, Maure, L, González-Ortiz, F, Benejam, B, Turton, M, Barroeta, I, Harrison, P, Videla, L, Ashton, NJ, Lleó, A, Zetterberg, H, Carmona-Iragui, M, Karikari, TK, Fortea, J, Blennow, K. Plasma p-tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.70172. PMID:40275833. IF:11.100(Q1/1D).

01/04/2025 Sex differences in the executive and behavioral reserve of autosomal dominant frontotemporal dementia

Castro, JG, Rubio-Guerra, S, Casaletto, KB, González, JS, Memel, M, Vaqué-Alcázar, L, Morcillo-Nieto, A, Arriola-Infante, J, Dols-Icardo, O, Bejanin, A, Belbin, O, Fortea, J, Alcolea, D, Carmona-Iragui, M, Barroeta, I, Santos-Santos, M, Saudinós, MBS, Matavera, IS, Heuer, HW, Forsberg, LK, Kantarci, K, Staffaroni, AM, Tartaglia, C, Rankin, KP, Boeve, B, Boxer, A, Rosen, HJ, Lleó, A, Illán-Gala, I. Sex differences in the executive and behavioral reserve of autosomal dominant frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.70070. PMID:40277045. IF:11.100(Q1/1D).

01/04/2025 Resistance and resilience to Alzheimer's disease in Down syndrome

Boyle, R, Koops, EA, Ances, B, Andrews, EJ, Arenaza-Urquijo, EM, Benjanin, A, Brickman, AM, Buckley, RF, Clas, GS, Costello, E, Coughlan, GT, Conley, AC, Deng, F, Faria, DD, Edwards, N, Flores-Aguilar, L, Fortea, J, Saidi, LG, Head, E, Hom, CL, Koenig, K, Lao, PT, Lengyel, I, Li, YJ, Loi, S, Loughrey, D, Mcglinchey, E, Newhouse, P, Pertierra, L, Prokopiou, PC, Qi, Q, Resende, EDF, Russell, J, Scanlon, CE, Schneider, C, Schultz, SA, Seto, M, Shaka, S, Soldan, A, Alcazar, LV, Weng, YH, Wilson, JE, Zaman, SH, Zsadanyi, SE, Hartley, S. Resistance and resilience to Alzheimer's disease in Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.70151. PMID:40289889. IF:11.100(Q1/1D).

01/04/2025 Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia

Liu, XL, de Boer, SCM, Cortez, K, Poos, JM, Illán-Gala, I, Heuer, H, Forsberg, LK, Casaletto, K, Memel, M, Appleby, BS, Barmada, S, Bozoki, A, Clark, D, Cobigo, Y, Darby, R, Dickerson, BC, Domoto-Reilly, K, Galasko, DR, Geschwind, DH, Ghoshal, N, Graff-Radford, NR, Grant, IM, Hsiung, GYR, Honig, LS, Huey, ED, Irwin, D, Kantarci, K, Léger, GC, Litvan, I, Mackenzie, IR, Masdeu, JC, Mendez, MF, Onyike, CU, Pascual, B, Pressman, P, Bayram, E, Ramos, EM, Roberson, ED, Rogalski, E, Bouzigues, A, Russell, LL, Foster, PH, Ferry-Bolder, E, Masellis, M, van Swieten, J, Jiskoot, L, Seelaar, H, Sanchez-Valle, R, Laforce, R, Graff, C, Galimberti, D, Vandenberghe, R, de Mendonça, A, Tiraboschi, P, Santana, I, Gerhard, A, Levin, J, Sorbi, S, Otto, M, Pasquier, F, Ducharme, S, Butler, CR, Le Ber, I, Finger, E, Rowe, JB, Synofzik, M, Moreno, F, Borroni, B, Boeve, BF, Boxer, AL, Rosen, HJ, Pijnenburg, YAL, Rohrer, JD, Tartaglia, MC. Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.14608. PMID:40277074. IF:11.100(Q1/1D).

01/04/2025 Sex differences in the clinical manifestation of autosomal dominant frontotemporal dementia

Memel, M, Staffaroni, AM, Ilan-Gala, I, Castro, JG, Kornak, J, Tartaglia, CM, Saloner, R, VandeBunte, AM, Paolillo, EW, Cadwallader, CJ, Chen, C, Gorno-Tempini, ML, Mandelli, M, Apostolova, L, Graff-Radford, N, Litvan, I, Bayram, E, Pressman, PS, Miyagawa, T, Mackenzie, I, Goldman, J, Darby, RR, Appleby, BS, Petrucelli, L, Gendron, T, Heuer, HW, Forseberg, LK, Rojas, JC, Boeve, BF, Brushaber, N, Domoto-Reilly, K, Ghoshal, N, Lapid, M, Pascual, B, Lee, S, Ramos, EM, Ramanan, V, Rademakers, R, Rascovsky, K, Pantelyat, A, Masdeu, JC, Snyder, A, Boxer, AL, Rosen, HJ, Casaletto, K. Sex differences in the clinical manifestation of autosomal dominant frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.14630. PMID:40277077. IF:11.100(Q1/1D).

01/04/2025 Long-term prognostic impact of the left anterior descending coronary artery as the STEMI-related culprit vessel: subanalysis of the EXAMINATION-EXTEND trial

Vidal-Calés, P, Bujak, K, Rinaldi, R, Salazar-Rodríguez, A, Ortega-Paz, L, Gómez-Lara, J, Jiménez-Díaz, V, Jiménez, M, Jiménez-Quevedo, P, Diletti, R, Bordes, P, Campo, G, Silvestro, A, Maristany, J, Flores, X, De Miguel-Castro, A, Iñiguez, A, Ielasi, A, Tespili, M, Lenzen, M, Gonzalo, N, Tebaldi, M, Biscaglia, S, Romaguera, R, Gómez-Hospital, JA, Serruys, PW, Sabaté, M, Brugaletta, S. Long-term prognostic impact of the left anterior descending coronary artery as the STEMI-related culprit vessel: subanalysis of the EXAMINATION-EXTEND trial. REC, interventional cardiology. 2025; 7(2)DOI:10.24875/RECICE.M24000488. PMID:. IF:(Q/D).

01/04/2025 Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.

Sivera Mascaró R, García Sobrino T, Horga Hernández A, Pelayo Negro AL, Alonso Jiménez A, Antelo Pose A, Calabria Gallego MD, Casasnovas C, Cemillán Fernández CA, Esteban Pérez J, Fenollar Cortés M, Frasquet Carrera M, Gallano Petit MP, Giménez Muñoz A, Gutiérrez Gutiérrez G, Gutiérrez Martínez A, Juntas Morales R, Ciano-Petersen NL, Martínez Ulloa PL, Mederer Hengstl S, Millet Sancho E, Navacerrada Barrero FJ, Navarrete Faubel FE, Pardo Fernández J, Pascual Pascual SI, Pérez Lucas J, Pino Mínguez J, Rabasa Pérez M, Sánchez González M, Sotoca J, Rodríguez Santiago B, Rojas García R, Turon-Sans J, Vicent Carsí V, Sevilla Mantecón T. Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.. Neurologia. 2025; 40(3)DOI:10.1016/j.nrleng.2024.02.008. PMID:38431252. IF:(Q/D).

01/04/2025 New scoring balloon to treat moderate-to-severe calcified coronary lesions. The first-in-man Naviscore study

Peñaranda, AS, Peregrina, EF, Kockar, MJ, del Blanco, BG, Romani, S, Moreiras, JM, Bermúdez, EP, Rodrigues, A, Ojeda, S, López, NG, Regueiro, A, Frutos, AS. New scoring balloon to treat moderate-to-severe calcified coronary lesions. The first-in-man Naviscore study. REC, interventional cardiology. 2025; 7(2)DOI:10.24875/RECICE.M24000484. PMID:. IF:(Q/D).

01/04/2025 Meteorin-like protein plasma levels are associated with worse outcomes in de novo heart failure

Anido-Varela, L, Aragón-Herrera, A, González-Maestro, A, Bellas, CT, Tarazón, E, Solé-González, E, Martínez-Sellés, M, Guerra-Ramos, JM, Carrasquer, A, Morán-Fernández, L, García-Vega, D, Seoane-Blanco, A, Moure-González, M, Seijas-Amigo, J, Rodríguez-Penas, D, García-Seara, J, Moraña-Fernández, S, Vázquez-Abuín, X, Roselló-Lletí, E, Portolés, M, Eiras, S, Agra, RM, Alvarez, E, González-Juanatey, JR, Feijóo-Bandín, S, Lago, F. Meteorin-like protein plasma levels are associated with worse outcomes in de novo heart failure. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55(4)DOI:10.1111/eci.14380. PMID:39834188. IF:3.600(Q1/2D).

01/04/2025 Geriatric conditions and invasive management in frail patients with NSTEMI. A subgroup analysis of a randomized clinical trial

Sanchis, J, Bueno, H, Garcia-Blas, S, Gomez-Hospital, JA, Marti, D, Martinez-Selles, M, Dominguez-Perez, L, Diez-Villanueva, P, Barrabes, JA, Marin, F, Villa, A, Sanmartin, M, Llibre, C, Sionis, A, Carol, A, Valero, E, Calvo, E, Morales, MJ, Elizaga, J, Gomez, I, Alfonso, F, del Blanco, BG, Formiga, F, Nunez, E, Nunez, J, Ariza-Sole, A. Geriatric conditions and invasive management in frail patients with NSTEMI. A subgroup analysis of a randomized clinical trial. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(4)DOI:10.1016/j.rec.2024.08.006. PMID:39270775. IF:4.900(Q1/2D).

01/04/2025 Peroral endoscopic myotomy (POEM) as a treatment for pediatric achalasia: multicenter study and first results

Villanueva, CL, Arbizu, EA, Goruppi, I, Lozano, NB, Bianchi, F, Martínez, AP, Pina, SM, Caballero, AYM, Murzi, M, Betroletti, F, Estremera, F, Guerrero, SB, Argente, CG. Peroral endoscopic myotomy (POEM) as a treatment for pediatric achalasia: multicenter study and first results. Gastroenterologia y Hepatologia. 2025; 48(4)DOI:10.1016/j.gastrohep.2024.502262. PMID:39343296. IF:1.900(Q3/7D).

01/04/2025 CNS manifestations in acute and chronic graft-versus-host disease

Lambert, N, Forte, F, El Moussaoui, M, Monseur, J, Raus, N, Polushin, A, Michonneau, D, Shultz, C, Hogan, WJ, Balaguer-Roselló, A, Gil-Perotín, S, Brijs, J, Chauvet, P, Gavriilaki, M, Carre, M, Dulamea, AO, Chalandon, Y, Salmenniemi, U, Duminuco, A, Ram, R, García-Cadenas, I, Porto, G, Nguyen, S, Smallbone, P, González-Vicent, M, Santoro, JD, Willems, E, Baron, F, Servais, S, Beguin, Y, Maquet, P. CNS manifestations in acute and chronic graft-versus-host disease. BRAIN. 2025; 148(4)DOI:10.1093/brain/awae340. PMID:39442000. IF:11.700(Q1/1D).

31/03/2025 Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction

Briones, AM, Hernanz, R, García-Redondo, AB, Rodriguez, C, Blanco-Colio, LM, Val-Blasco, A, Alonso, MJ, Salaices, M. Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2025; 136(5)DOI:10.1111/bcpt.70026. PMID:40159875. IF:3.300(Q2/4D).

30/03/2025 Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis

Afferi, L, Jahn, B, Kelkar, AH, Dijk, SW, Feldman, ZM, Ward, ZJ, Moschini, M, Cathomas, R, Bellmunt, J, Gallioli, A, Breda, A, Fankhauser, CD, Mattei, A, Chang, SL, Siebert, U. Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis. WORLD JOURNAL OF UROLOGY. 2025; 43(1)DOI:10.1007/s00345-025-05584-7. PMID:40159560. IF:2.900(Q2/3D).

29/03/2025 The Spanish GIRO Guideline: A Paradigm Shift in the Management of Obesity in Adults

Lecube, A, Azriel, S, Barreiro, E, Blay, G, Carretero-Gómez, J, Ciudin, A, Fernández, JM, Flores, L, de Hollanda, A, Martínez, E, Miñambres, I, Moizé, V, Morales, C, Ramírez, V, Salvador, J, Soler, MJ, Supervía, M, Valenti, V, Vicente-Rodríguez, G, Vilarrasa, N, Malagón, MM. The Spanish GIRO Guideline: A Paradigm Shift in the Management of Obesity in Adults. Obesity Facts. 2025; 18(4)DOI:10.1159/000544880. PMID:40159422. IF:4.700(Q1/2D).

28/03/2025 Interindividual variability and its impact on the effectiveness of Janus kinase inhibitors in rheumatoid arthritis treatment

Martinez-Molina, C, Vidal, S, Diaz-Torne, C, Park, HS, Corominas, H. Interindividual variability and its impact on the effectiveness of Janus kinase inhibitors in rheumatoid arthritis treatment. Frontiers in Medicine. 2025; 12DOI:10.3389/fmed.2025.1512501. PMID:40224626. IF:3.000(Q1/2D).

28/03/2025 Beyond the status quo: when disease volume and metastatic timing are not enough to personalize treatment in mHSPC

Borque-Fernando, A, Alonso-Gordoa, T, Juan-Fita, MJ, Campos, FL, Pérez-Fentes, DA, Vilaseca, A, Agut, CM, Usán, P, Rey, PM. Beyond the status quo: when disease volume and metastatic timing are not enough to personalize treatment in mHSPC. Future Oncology. 2025; 21(8)DOI:10.1080/14796694.2025.2468569. PMID:40029138. IF:2.600(Q3/6D).

27/03/2025 Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study

Ivain, P, Baksh, A, Saini, F, Idris, M, Tamayo-Elizalde, M, Wells, J, Benejam, B, Loosli, SV, Sandkühle, K, Wlasich, E, Wagemann, O, Levin, J, Martet, D, Sacco, S, Falquero, S, Clert, M, Rebillat, AS, Khoo, WM, Smith, MA, Beresford-Webb, J, Zaman, S, Carmona-Iragui, M, Videla, L, Fortea, J, Langballe, EM, Medboen, IT, Larsen, FK, Baldimtsi, E, Paradisi, R, Ntailakis, P, Tsolaki, M, Papantoniou, G, Mcglinchey, E, Mccarron, M, Kennelly, S, Strydom, A. Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study. ALZHEIMERS & DEMENTIA. 2025; 21(3)DOI:10.1002/alz.70071. PMID:40145416. IF:11.100(Q1/1D).

26/03/2025 Factors in Time to Full Approval or Withdrawal for Anticancer Medicines Granted Accelerated Approval by the FDA

Tibau, A, Hwang, TJ, Romano, A, Borrell, M, Gich, I, Molto, C, Kesselheim, AS. Factors in Time to Full Approval or Withdrawal for Anticancer Medicines Granted Accelerated Approval by the FDA. JAMA Network Open. 2025; 8(3)DOI:10.1001/jamanetworkopen.2025.2026. PMID:40136298. IF:9.700(Q1/1D).

26/03/2025 Strategy for drug repurposing in fibroadipogenic replacement during muscle wasting: application to duchenne muscular dystrophy

Matthews, I, Mehra, P, Suárez-Calvet, X, Piñol-Jurado, P, Cox, D, Justian, V, Carrasco-Rozas, A, Laidler, Z, Bowey, A, Rushton, P, López-Fernández, S, Díaz-Manera, J, Fernández-Simón, E. Strategy for drug repurposing in fibroadipogenic replacement during muscle wasting: application to duchenne muscular dystrophy. Frontiers in Cell and Developmental Biology. 2025; 13DOI:10.3389/fcell.2025.1505697. PMID:40206397. IF:4.300(Q1/1D).

25/03/2025 Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis

Lopez-Rey, BG, Carot-Sans, G, Ouchi, D, Torres, F, Pontes, C. Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis. Frontiers in Pharmacology. 2025; 16DOI:10.3389/fphar.2025.1548997. PMID:40201693. IF:4.800(Q1/2D).

25/03/2025 Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis

Mondesert, E, Delaby, C, de la Cruz, E, Kuhle, J, Benkert, P, Pradeilles, N, Duchiron, M, Morchikh, M, Camu, W, Cristol, JP, Hirtz, C, Esselin, F, Lehmann, S. Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis. NEUROLOGY. 2025; 104(6)DOI:10.1212/WNL.0000000000213400. PMID:40009787. IF:8.500(Q1/1D).

25/03/2025 Can ICD Electrograms Help Ventricular Tachycardia Ablation? Results From the Multicenter Randomized AIDEG-VTA Trial

Criado, JLI, Ortiz, M, García-Fernández, J, Martínez-Alday, JD, Font, ER, Moreno, J, López, MA, Almor, JM, Gil, ML, Medina, DG, Granell, RR, Peinado, RP, Gelizo, VB, Muñoz, JJS, Medina, O, Díaz-Parreño, SA, Criado, AI, Gonzalez, JM, Merodio, JMO, Almendral, J. Can ICD Electrograms Help Ventricular Tachycardia Ablation? Results From the Multicenter Randomized AIDEG-VTA Trial. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2025; 85(11)DOI:10.1016/j.jacc.2024.10.104. PMID:39772368. IF:22.300(Q1/1D).

25/03/2025 Inositol 1,4,5-Trisphosphate Receptor 1 Gain-of-Function Increases the Risk for Cardiac Arrhythmias in Mice and Humans

Sun, B, Ni, MK, Li, YH, Song, ZP, Wang, H, Zhu, HL, Wei, JH, Belke, D, Cai, ST, Guo, WT, Yao, JJ, Tian, SS, Estillore, JP, Wang, RW, Sondergaard, MT, Brohus, M, Rohde, PD, Mu, YX, Vallmitjana, A, Benitez, R, Hove-Madsen, L, Overgaard, MT, Fishman, GI, Chen, J, Sanatani, S, Wilde, AAM, Fill, M, Ramos-Franco, J, Nyegaard, M, Chen, SRW. Inositol 1,4,5-Trisphosphate Receptor 1 Gain-of-Function Increases the Risk for Cardiac Arrhythmias in Mice and Humans. CIRCULATION. 2025; 151(12)DOI:10.1161/CIRCULATIONAHA.124.070563. PMID:39655431. IF:38.600(Q1/1D).

25/03/2025 Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort study

Tort-Merino, A, Pérez-Millan, A, Falgàs, N, Borrego-ecija, S, Esteller, D, Bosch, B, Castellví, M, Juncà-Parella, J, del Val-Guardiola, A, Fernández-Villullas, G, Antonell, A, Sanchez-Saudinós, MB, Rubio-Guerra, S, Zhu, NL, García-Martínez, M, Pozueta, A, Estanga, A, Ecay-Torres, M, de Luis, CL, Tainta, M, Altuna, M, Rodríguez-Rodríguez, E, Sánchez-Juan, P, Martínez-Lage, P, Lleó, A, Fortea, J, Illán-Gala, I, Balasa, M, Lladó, A, Rami, L, Sánchez-Valle, R. Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort study. ALZHEIMERS & DEMENTIA. 2025; 21(3)DOI:10.1002/alz.70016. PMID:40133248. IF:11.100(Q1/1D).

24/03/2025 Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population

Echeverry-Quiceno, LM, Llambrich, S, Heredia-Lidón, A, Giménez, S, Rozalem-Aranha, M, Inampudi, P, Heuzé, Y, Sevillano, X, Fortea, J, Martinez-Abadias, N, Alzheimers Dis Neuroimaging Initiative. Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population. FASEB JOURNAL. 2025; 39(6)DOI:10.1096/fj.202403009R. PMID:40123509. IF:4.200(Q1/2D).

22/03/2025 SSX and SS18-SSX Antibodies as Additional Tools for Diagnosing Undifferentiated Neoplasms With the EWSR1::SSX3 Fusion

Machado, I, Llombart-Bosch, A, Fumagalli, C, Antonescu, CR. SSX and SS18-SSX Antibodies as Additional Tools for Diagnosing Undifferentiated Neoplasms With the EWSR1::SSX3 Fusion. GENES CHROMOSOMES & CANCER. 2025; 64(3)DOI:10.1002/gcc.70044. PMID:40119747. IF:2.800(Q2/5D).

21/03/2025 Prevalence, diagnostic accuracy, and healthcare utilization patterns in patients with COPD in primary healthcare: a population-based study

Vila, M, Sisó-Almirall, A, Ocaña, A, Agustí, A, Faner, R, Borras-Santos, A, González-de Paz, L. Prevalence, diagnostic accuracy, and healthcare utilization patterns in patients with COPD in primary healthcare: a population-based study. npj Primary Care Respiratory Medicine. 2025; 35(1)DOI:10.1038/s41533-025-00419-9. PMID:40118910. IF:4.700(Q1/1D).

21/03/2025 Machine learning allows robust classification of lung neoplasm tissue using an electronic biopsy through minimally-invasive electrical impedance spectroscopy

Company-Se, G, Pajares, V, Rafecas-Codern, A, Riu, PJ, Rosell-Ferrer, J, Bragós, R, Nescolarde, L. Machine learning allows robust classification of lung neoplasm tissue using an electronic biopsy through minimally-invasive electrical impedance spectroscopy. Scientific Reports. 2025; 15(1)DOI:10.1038/s41598-025-94826-0. PMID:40119130. IF:3.900(Q1/2D).

21/03/2025 Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)

Jiménez-Vicente, C, Esteve, J, Baile-González, M, Pérez-López, E, Calvo, CM, Aparicio, C, Ormategi, IO, Esquirol, A, Peña-Muñoz, F, Fernandez-Luis, S, Fernando, IH, González-Rodríguez, AP, López-García, A, López-Lorenzo, JL, Torrado, T, Marín, AJS, Fleytas, CA, García, L, Villar, S, Filaferro, S, Balsalobre, P, Cascón, MJP, Salas, MQ. Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC). Blood Cancer Journal. 2025; 15(1)DOI:10.1038/s41408-025-01223-x. PMID:40118819. IF:11.600(Q1/1D).

20/03/2025 When should the nephrologist think about genetics in patients with glomerular diseases?

Torra, R, Barros, X, Díaz-Encarnación, M, Fayos, L, Furlano, M, Pilco, M, Pybus, M, Shabaka, A, Viera, E, Ars, E. When should the nephrologist think about genetics in patients with glomerular diseases?. Clinical Kidney Journal. 2025; 18(3)DOI:10.1093/ckj/sfaf044. PMID:40115110. IF:4.600(Q1/2D).

20/03/2025 Comparison of extended and standard lymph node dissection in radical cystectomy for urothelial bladder cancer: a systematic review and meta-analysis

Slusarczyk, A, Scilipoti, P, Marcq, G, Pradere, B, Contieri, R, Krajewski, W, Laukthina, E, Del Giudice, F, Longoni, M, Gallioli, A, Abu-Ghanem, Y, Khan, MS, Soria, F, Albisinni, S, Rouprêt, M, Radziszewski, P, Montorsi, F, Briganti, A, Moschini, M. Comparison of extended and standard lymph node dissection in radical cystectomy for urothelial bladder cancer: a systematic review and meta-analysis. WORLD JOURNAL OF UROLOGY. 2025; 43(1)DOI:10.1007/s00345-025-05549-w. PMID:40111501. IF:2.900(Q2/3D).

20/03/2025 Exploratory analysis of the proteomic profile in plasma in adults with Down syndrome in the context of Alzheimer's disease

Wagemann, O, Nübling, G, Martínez-Murcia, FJ, Wlasich, E, Loosli, SV, Sandkühler, K, Stockbauer, A, Prix, C, Katzdobler, S, Petrera, A, Hauck, SM, Fortea, J, Romero-Zaliz, R, Jiménez-Mesa, C, Sáez, JMG, Höglinger, G, Levin, J. Exploratory analysis of the proteomic profile in plasma in adults with Down syndrome in the context of Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2025; 21(3)DOI:10.1002/alz.70040. PMID:40110647. IF:11.100(Q1/1D).

19/03/2025 Insights on the cognitive enhancement effect of desvenlafaxine in major depressive disorder

Vicent-Gil, M, Trujols, J, Sagues, T, Serra-Blasco, M, Navarra-Ventura, G, Mantellini, CL, Crivillés, S, Portella, MJ, Cardoner, N. Insights on the cognitive enhancement effect of desvenlafaxine in major depressive disorder. Annals of General Psychiatry. 2025; 24(1)DOI:10.1186/s12991-025-00552-2. PMID:40108685. IF:3.100(Q2/4D).

19/03/2025 Exploring Social Inequalities in Post-pandemic Labour Market Shifts and Job Dissatisfaction in Barcelona: Insights From a Southern European City.

Pericas C, Vilaplana-Carnerero C, Martínez-Riveros H, Artazcoz L, Bartoll-Roca X, Álamo-Junquera D, Arcas MM, Rius C, Grau M. Exploring Social Inequalities in Post-pandemic Labour Market Shifts and Job Dissatisfaction in Barcelona: Insights From a Southern European City.. Cureus. 2025; 17(3)DOI:10.7759/cureus.80847. PMID:40255756. IF:(Q/D).

19/03/2025 Nonbacterial Thrombotic Endocarditis of the Aortic Valve in a Patient With Antiphospholipid Syndrome.

Gonzalez C, Salido M, Fernandez J, Rodriguez A, Duran A, López L, Sionis A, Viladés D, Descalzo M. Nonbacterial Thrombotic Endocarditis of the Aortic Valve in a Patient With Antiphospholipid Syndrome.. JACC. Case reports. 2025; 30(6 Pt 2)DOI:10.1016/j.jaccas.2024.102963. PMID:40155123. IF:(Q/D).

18/03/2025 Buckberg versus Del Nido in isolated aortic valve replacement: a prospective, two-centre, randomized trial

Tauron-Ferrer, M, Roselló-Díez, E, Muñoz-Guijosa, C, Fernández-DeVinzenzi, C, Montiel, J, Casellas, S, Irabien-Ortiz, A, Corominas-García, L, Piedra, C, Julià, I, Fernández, C, Cegarra, V, Guadalupe, N, Molina, M, Tabilo, JF, Gotsens-Asenjo, C, Sobre, C, Gomez, V, Berastegui, E, Ginel, AJ. Buckberg versus Del Nido in isolated aortic valve replacement: a prospective, two-centre, randomized trial. Interdisciplinary Cardiovascular And Thoracic Surgery. 2025; 40(3)DOI:10.1093/icvts/ivaf054. PMID:40065513. IF:1.300(Q3/7D).

17/03/2025 The Role of Integrin ß1D Mislocalization in the Pathophysiology of Calpain 3-Related Limb-Girdle Muscular Dystrophy

Valls, A, Ruiz-Roldán, C, Immanuel, J, Alonso-Martín, S, Gallardo, E, Fernández-Torrón, R, Bonilla, M, Lersundi, A, Hernández-Laín, A, Domínguez-González, C, Vílchez, JJ, Iruzubieta, P, de Munain, AL, Sáenz, A. The Role of Integrin ß1D Mislocalization in the Pathophysiology of Calpain 3-Related Limb-Girdle Muscular Dystrophy. Cells. 2025; 14(6)DOI:10.3390/cells14060446. PMID:40136695. IF:5.200(Q2/3D).

14/03/2025 New treatments in Alzheimer's disease

Lleó, A. New treatments in Alzheimer's disease. MEDICINA CLINICA. 2025; 164(5)DOI:10.1016/j.medcli.2024.10.011. PMID:39616028. IF:2.100(Q2/3D).